Immunic
IMUX
IMUX
62 hedge funds and large institutions have $34M invested in Immunic in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
39% less capital invested
Capital invested by funds: $56.1M → $34M (-$22.1M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
62
Holding in Top 10
–
Calls
$738K
Puts
$521K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$1.54M | |
| 3 | +$1.28M | |
| 4 |
CC
Commodore Capital
New York
|
+$1.27M |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$931K |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$1.98M | |
| 3 | -$854K | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$758K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$693K |